Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  S. Hasegawa.  Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma , 2014, General Thoracic and Cardiovascular Surgery.

[3]  T. Yamanaka,et al.  A feasibility study of induction pemetrexed plus cisplatin followed by pleurectomy/decortication aimed at macroscopic complete resection for malignant pleural mesothelioma. , 2013, Japanese journal of clinical oncology.

[4]  B. Passlick,et al.  Changes in lung function after surgery for mesothelioma , 2013, Asian cardiovascular & thoracic annals.

[5]  V. Rusch,et al.  Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  H. Kuwano,et al.  Hospital volume and outcomes of cardiothoracic surgery in Japan: 2005–2009 national survey , 2012, General Thoracic and Cardiovascular Surgery.

[7]  Benjamin M. Robinson,et al.  Malignant pleural mesothelioma: an epidemiological perspective. , 2012, Annals of cardiothoracic surgery.

[8]  S. Bölükbas,et al.  Prospective Study on Functional Results After Lung-Sparing Radical Pleurectomy in the Management of Malignant Pleural Mesothelioma , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  W. Al-Refaie,et al.  What happens to racial and ethnic minorities after cancer surgery at American College of Surgeons National Surgical Quality Improvement Program hospitals? , 2012, Journal of the American College of Surgeons.

[10]  J. Peto,et al.  Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study , 2011, The Lancet. Oncology.

[11]  Tsun-Jen Cheng,et al.  Global Magnitude of Reported and Unreported Mesothelioma , 2011, Environmental health perspectives.

[12]  P. V. Van Schil,et al.  Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial , 2010, European Respiratory Journal.

[13]  P. Davies,et al.  UK pneumonectomy outcome study (UKPOS): a prospective observational study of pneumonectomy outcome , 2009, Journal of cardiothoracic surgery.

[14]  C. Obasaju,et al.  Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  T. Yamanaka,et al.  A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma. , 2008, Japanese journal of clinical oncology.

[16]  豊 木村,et al.  胃癌手術におけるCommon Terminology Criteria for Adverse Events v3.0を利用した合併症の評価 , 2009 .

[17]  N. Saijo,et al.  Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patients. , 2008, Japanese journal of clinical oncology.

[18]  V. Seshan,et al.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. , 2008, The Journal of thoracic and cardiovascular surgery.

[19]  T. Nakano.  Current therapies for malignant pleural mesothelioma , 2008, Environmental health and preventive medicine.

[20]  D. Boffa,et al.  Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. , 2008, The Journal of thoracic and cardiovascular surgery.

[21]  BTS statement on malignant mesothelioma in the UK, 2007 , 2007, Thorax.

[22]  F. Rea,et al.  Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results. , 2007, Lung cancer.

[23]  R. Stupp,et al.  Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  K. Rosenzweig,et al.  Induction Chemotherapy, Extrapleural Pneumonectomy, and Postoperative High-Dose Radiotherapy for Locally Advanced Malignant Pleural Mesothelioma: A Phase II Trial , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[25]  P. Jänne,et al.  Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  D. Sugarbaker.  Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  Ken Takahashi,et al.  Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. , 2006, American journal of industrial medicine.

[28]  B. Robinson,et al.  Advances in malignant mesothelioma. , 2005, The New England journal of medicine.

[29]  R. Stahel,et al.  Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Byrne,et al.  Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  K. Rosenzweig,et al.  A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. , 2001, The Journal of thoracic and cardiovascular surgery.

[32]  T. Nakano,et al.  Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma , 1999, Cancer.

[33]  V. Rusch.  A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. , 1995, Chest.

[34]  V. Rusch,et al.  A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  J Espinosa Arranz,et al.  [Malignant mesothelioma]. , 1994, Medicina clinica.

[36]  D. Sugarbaker,et al.  Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. , 1992, The Annals of thoracic surgery.